Formulation and optimization of mucoadhesive nanodrug delivery system of acyclovir

Journal of Young Pharmacists

Volumn 3, Issue 4, 2011, Pages 275-283

  Bhosale, U V ^a   Kusum Devi, V ^a   Jain, N ^a  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

acyclovir; mucoadhesive; nanoparticles; poly (lactic co glycolic acid)

Indexed keywords

ACICLOVIR; POLOXAMER; POLYCARBOPHIL; POLYGLACTIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; IN VITRO STUDY; INTESTINE MUCOSA; MALE; MUCOADHESION; NANOENCAPSULATION; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RAT; SUSTAINED DRUG RELEASE;

EID: 82955225424     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.4103/0975-1483.90236     Document Type: Article

References (25)

1. Tran T, Druce JD, Catton MC, Kelly H, Birch CJ. Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003. Sex Transm Infect 2004;80:277-9. (Pubitemid 39070788)
2. Emmert DH. Treatment of common cutaneous Herpes Simplex Virus infections. Am Fam Physician 2000;61:1697-704.
3. Wagstaff AG, Faulds D, Goa KL. Aciclovir: A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994;47:153-205. (Pubitemid 24032382)
4. Ruhnese M, Sandstorm F, Andersson B. Treatment of recurrent genital herpes simplex infection with acyclovir. J Antimicrob Chemother 1985;16:621-8. (Pubitemid 16215654)
5. Fuertes I, Miranda A, Millan M, Caraballo I. Estimation of the percolation thersholds in acyclovir hydrophilic matrix tablets. Eur J Pharm Biopharm 2006;64:336-42. (Pubitemid 44585200)
6. Jalon De EG, Blanco-Prieto MJ, Ygartua P, Santoyo S. Increased efficacy of acyclovir-loaded microparticles against herpes simplex virus type 1 in cell culture. Eur J Pharm Biopharm 2003;56:183-7. (Pubitemid 37072101)
7. Rossi S, Sandri G, Ferrari F, Bonferoni MC, Caramella C. Buccal delivery of acyclovir from lms based on chitosan and polyacrylic acid. Pharm Dev Technol 2003;8:199-208. (Pubitemid 36548984)
8. O'Brien JJ, Campoli-Richards DM. Acyclovir: An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1989;37:233-309. (Pubitemid 19083613)
9. Allemann E, Leroux JC, Gurny R. Polymeric nano-and microparticles for the oral delivery of peptides and peptidomimetics. Adv Drug Deliv Rev 1998;34:171-89. (Pubitemid 28535111)
10. Smart, JD, KellawayIW, Worthington HEC. J Pharm Pharmacol 1984;36:295.
11. Kamath KR, Park K. In Encyclopedia of Pharmaceutical Technology. Vol. 10. New York: Marcel Dekker; vol.10, 1988. p. 133-64.
12. Phutane P, Shidhaye S, Lotlikar V, Ghule A, Sutar S, Kadam V. In vitro evaluation of novel sustained release microspheres of glipizide prepared by the emulsion solvent diffusion-evaporation method. J Young Pharma 2010;2:35-41.
13. Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsules deposition by interfacial polymer deposition following solvent deplacement. Int J Pharm 1989;55:R1-4. (Pubitemid 19247505)
14. Freitas MN, Marchetti JM. Nimesulide PL. A microspheres as a potential sustained release system for the treatment of inflammatory diseases. Int J Pharma 2005;13:201-11. (Pubitemid 40558803)
15. Gohel M, Patel M, Amin A, Agarwal A, Dave R, Bariya N. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS Pharm Sci Tech 2004;5:36.
16. Jain S, Srinath MS, Narendra C, Reddy SN, Sindhu A. Development of a floating dosage form of ranitidine hydrochloride by statistical optimization technique. J Young Pharma 2010;2:342-9.
17. Ramteke S, Umamaheshwari RB, Jain NK. Clarithromycin based oral sustained release nanoparticulate system. Indian J Pharm Sci 2006;68:479-84. (Pubitemid 44599821)
18. Park GB, Shao Z, Mitra AK. Acyclovir permeation enhancement across intestinal and nasal mucosae by bile salt-acylcarnitine mixed micelles. Pharm Res 1992;9:1262-7.
19. Feng SS, Mu L, Win KY, Huang G. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr Med Chem 2004;11:413-24. (Pubitemid 38294346)
20. Murakami H, Kawashima Y, Niwa T, Hino T, Takeuchi H. Influence of the degrees of hydrolyzation and polymerization of poly(vinylalcohol) on the preparation and properties of poly(-lactide-co-glycolide) nanoparticles. Int J Pharm 1997;149:43-9. (Pubitemid 27193418)
21. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000;21:2475-90.
22. Ashish K, Mehta P, Yadav KS, Krutika KS. Nimodipine Loaded PLGA Nanoparticles: Formulation optimization using factorial design, characterization and in vitro evaluation. Curr Drug Deliv 2007;4:185-93 (Pubitemid 47025402)
23. Nixon JR. Release characterization of microcapsules. In: Lim F, editor. Biomedical applications of microcapsulation. Boca Raton, FL: CRC Press; 1983.
24. Costa P, Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-33. (Pubitemid 32288781)
25. Ritger PL, Peppas NA. A simple equation for description of solute release: Fickian and non-Fickian release from nonswellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1992;5:23-36. (Pubitemid 17106643)